Rapid detection and isolation of coronavirus disease 2019 (COVID-19) patients is the only means of reducing hospital transmission. We describe the impact of implementation of on-site severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) testing on reducing turnaround time, isolation duration, pathology test ordering, and antibiotic use in patients who do not have COVID-19.
All Keywords
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, pathology, Coronavirus disease 2019, coronavirus, hospital, Transmission, RT-PCR, virus, polymerase chain reaction, implementation, Patient, Isolation, Rapid, respiratory, antibiotic use, Chain Reaction, Respiratory Coronavirus, polymerase chain, reducing, 【제목키워드】 SARS-CoV-2, coronavirus, virus, Impact, Isolation, respiratory, resource, Respiratory Coronavirus,
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, pathology, Coronavirus disease 2019, coronavirus, hospital, Transmission, RT-PCR, virus, polymerase chain reaction, implementation, Patient, Isolation, Rapid, respiratory, antibiotic use, Chain Reaction, Respiratory Coronavirus, polymerase chain, reducing, 【제목키워드】 SARS-CoV-2, coronavirus, virus, Impact, Isolation, respiratory, resource, Respiratory Coronavirus,
코로나바이러스 감염증 2019(COVID-19) 환자의 신속한 감지 및 격리는 병원 전염을 줄이는 유일한 수단입니다. 우리는 현장 중증 급성 호흡기 코로나바이러스 2(SARS-CoV-2) 역전사 중합효소 연쇄 반응(RT-PCR) 테스트의 시행이 소요 시간, 격리 기간, 병리학 테스트 주문 및 항생제 사용을 줄이는 데 미치는 영향을 설명합니다. COVID-19에 감염되지 않은 환자에서.